Apatinib as an alternative therapy for advanced hepatocellular carcinoma

Angiogenesis plays an important role in the occurrence and development of tumors. Registered tyrosine kinase inhibitors targeting vascular endothelial growth factor reduce angiogenesis. Apatinib, a tyrosine kinase inhibitor, can specifically inhibit vascular endothelial growth factor receptor 2, sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi-Hao, Cao, Man-Qing, Li, Xiu-Xiu, Zhang, Ti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643208/
https://www.ncbi.nlm.nih.gov/pubmed/33200015
http://dx.doi.org/10.4254/wjh.v12.i10.766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643208/
https://www.ncbi.nlm.nih.gov/pubmed/33200015
http://dx.doi.org/10.4254/wjh.v12.i10.766

Ejemplares similares